SLEEP APNEA IMPLANTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Sleep Apnea Implants Market, By Product (Phrenic nerve stimulator, Hypoglossal neurostimulation devices, Bone screw implant system, Flexible tongue retractor system, Palatal implants), By Indication (Central sleep apnea, Obstructive sleep apnea), By End User (Hospitals & Clinics, Ambulatory surgical centers, Home care settings, Diagnostic Laboratories, Office based clinics), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

On March 20, 2024, LivaNova PLC, a global medical technology company, announced that its OSPREY clinical study on the aura6000 Hypoglossal Nerve Stimulator System for obstructive sleep apnea (OSA) had achieved a positive predictive outcome and will end enrollment early. The study shows over a 97.5% chance of meeting its primary endpoint. LivaNova has informed the FDA and trial sites of this milestone.
In June, 2023, Inspire Medical Systems gained FDA approval for an expanded use of its Inspire nerve-stimulating implant, which helps treat obstructive sleep apnea by stimulating a jaw nerve to keep the airway open. The device is controlled by the patient via a remote.
In November, 2023, Tampa General Hospital (TGH) achieved a significant milestone by performing Florida's first pediatric Inspire implant surgery. This landmark procedure, conducted at TGH's renowned ENT Institute, was for a young patient with Down syndrome and sleep apnea, highlighting the hospital's commitment to multidisciplinary pediatric care.